EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $290,000 | -27.0% | 10,984 | +23.0% | 0.00% | 0.0% |
| Q2 2022 | $397,000 | -11.4% | 8,933 | -1.2% | 0.00% | 0.0% |
| Q1 2022 | $448,000 | -9.1% | 9,041 | -6.7% | 0.00% | 0.0% |
| Q4 2021 | $493,000 | -92.4% | 9,692 | -87.6% | 0.00% | -93.3% |
| Q1 2017 | $6,503,000 | -22.9% | 78,412 | -26.2% | 0.02% | -25.0% |
| Q4 2016 | $8,430,000 | +31.9% | 106,256 | +16.4% | 0.02% | +33.3% |
| Q3 2016 | $6,389,000 | +42.0% | 91,275 | -21.3% | 0.02% | +36.4% |
| Q2 2016 | $4,500,000 | +19.4% | 116,020 | +24.6% | 0.01% | +22.2% |
| Q1 2016 | $3,770,000 | -49.7% | 93,108 | +10.3% | 0.01% | -47.1% |
| Q4 2015 | $7,488,000 | +76.4% | 84,450 | +47.3% | 0.02% | +88.9% |
| Q3 2015 | $4,246,000 | +33.9% | 57,350 | +46.3% | 0.01% | +50.0% |
| Q2 2015 | $3,170,000 | – | 39,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |